This study reports on leukemia inhibitory factor (LIF) in human articular connective tissues. Biologically active LIF is present in synovial fluids from patients with osteoarthritis and at higher titers in samples from patients with rheumatoid arthritis. Cultured human synoviocytes and articular chondrocytes produced biologically active LIF and synthesized and secreted LIF proteins that migrated in SDS PAGE at -43 kD. This was increased after stimulation with IL-1,6.
Introduction
Cytokines are developmental and homeostatic regulators of joint tissue cells and pathogenetic mediators of connective tis-sue destruction in arthritis. IL-1 and (TNF)' are known as important catabolic factors that induce the production of proteases and PGE2 and inhibit the formation of extracellular martix components (1) (2) (3) (4) . IL-6 (reviewed in reference 5) which is induced by IL- 1 and TNF does not induce the production ofproteases but rather stimulates the synthesis of protease inhibitors by connective tissue cells (6) and hepatocytes (7, 8) . In addition, IL-6 is a stimulator of chondrocyte proliferation (9) . A separate group of cytokines, referred to as intercrines contains chemotactic factors for monocytes, lymphocytes and neutrophils (reviewed in reference 10). Most ofthese cytokines are produced by synovium and chondrocytes and can be found in synovial effusions at higher titers usually in more inflammatory arthropathies ( 1 1-19 ).
Leukemia inhibitory factor (LIF; reviewed in references 20 and 21 ) is a cytokine that was characterized on the basis of its ability to induce differentiation of murine myeloid leukemia cells (22) (23) (24) . Other important effects on hematopoietic cells include the stimulation of bone marrow blasts and of megakaryocytes (25, 26) . LIF has been shown to inhibit differentiation ofembryonic stem cells (27) , to promote the generation of sensory (28) and cholinergic (29) neurons, and to stimulate a set of hepatic acute phase proteins that is similar to that induced by IL-6 (30) . LIF shares with TNF the ability to inhibit the expression of lipoprotein lipase ( 31 ) .
First evidence in support of a role of LIF in connective tissue metabolism was obtained from studies on bone where the overexpression of LIF resulted in the accumulation of excess osteoblasts in the marrow and new bone formation (32, 33) . In neonatal mouse calvaria LIF stimulated bone resorption in a PGE2-dependent mechanism and an increase in the number of osteoclasts (34) . LIF appears to stimulate osteoblasts directly and it induces the expression of alkaline phosphatase. LIF activation of osteoclasts probably results from the indirect activation of osteoclasts by osteoblasts, since only the latter express LIF receptors (35) (36) (37) .
No information is available on the expression of LIF by joint tissue cells and potential effects on their function. This study reports on the presence of LIF in synovial fluids, the regulation of LIF production by human articular chondrocytes and synoviocytes and its expression in cartilage and synovium.
Methods
Chondrocyte isolation and culture. Cartilage was obtained at autopsy from donors without known history of joint disease. For all experi-ments reported here, cartilage from the femoral condyles and tibial plateaus of the knee joints was used. At autopsy, cartilage slices were prepared and washed with DME (Whittaker Bioproducts, Walkerville, MD). Cartilage was minced with a scalpel and treated with trypsin (10% vol/vol) for 15 min in a 37°C waterbath. The samples were transferred to DME containing 5% FBS, penicillin-streptomycin-fungizone, and 2 mg/ml clostridial collagenase type IV (Sigma Chemical Co., St. Louis, MO) and digested for 3 h on a gyratory shaker until the tissue fragments were dissolved. The cells were washed three times and cultured as primary chondrocytes. Chondrocytes from different donors were always cultured separately and each experiment was performed with replicate flasks of chondrocyte cultures from the same donor.
Where indicated, subcultured cells (passages 1-8) were trypsinized from T175 flasks and plated in 96-well plates at 5.000-20.000 cells per well in DME 1% FBS. The media was removed, the wells were washed twice with serum-free DME and culture was continued in DME supplemented with L-glutamine and antibiotics.
Primary chondrocytes were cultured in T175 flasks for 24 h after isolation from cartilage in DME 5% FBS. The cells were nonadherent at that time point. They were collected, washed twice in serum-free media and plated in serum-free media as described above. For cartilage organ culture experiments, slices ofnormal knee cartilage ( -0.8 x 0.5 x 0.2 cm) were prepared, weighed, and cultured in 12-well plates.
Synoviocyte isolation and culture. Synovial tissues were obtained at autopsy from donors without known history ofjoint disease or at the time of total hip or knee replacement from patients with rheumatoid arthritis (RA) or osteoarthritis (OA). The tissues were minced with a scalpel and treated with trypsin (10% vol/vol) for 15 min in a 37°C waterbath. The samples were transferred to DME containing 5% FBS, penicillin-streptomycin-fungizone and 2 mg/ml clostridial collagenase type IV (Sigma Chemical Co.) and digested for 3 h on a gyratory shaker until the tissue fragments were digested. The cells were washed three times and the adherent cells were cultured as primary synoviocytes.
Synovialfluids. Synovial fluids (all from kneejoints) were obtained from five patients with seropositive RA and five patients with OA. All patients with RA were on remittive therapy and nonsteroidal anti-inflammatory drugs. Three patients received low-dose oral prednisone. The OA patients were on nonsteroidal anti-inflammatory drugs. None ofthe patients received intraarticular steroid injections for at least 3 mo into the same knee from which the sample was taken. Synovial fluids were processed as described earlier ( 15 ) .
Metabolic labeling and immunoprecipitation. Synoviocytes or chondrocytes were maintained in T175 flasks in DME containing 10% FBS, L-glutamine and antibiotics. For Sepharose was added for an additional 2 h. The precipitates were washed five times with PBS containing 0.05% Tween-80, 0.1% Triton X-100, and 1 mM PMSF followed by two washes in PBS. The beads were boiled for 5 min in Laemmli sample buffer and the proteins were separated on 12.5% polyacrylamide gels under reducing conditions. After staining with Coomassie Blue the gels were treated with Amplify (Amersham Corp., Arlington Heights, IL) for 1 h, dried, and exposed to Kodak XAR film (Eastman Kodak Co., Rochester, NY) at -70°C for 24 h.
RNA probe preparation. The LIF probe was generated by polymerase chain reaction (PCR), using genomic DNA from a hepatoma cell line (HepG2) as a template. PCR reactions (in a volume of 100 M1) contained hybridizing to positions 1391-1414 in exon 3. The reactions were heated for 5 min at 94°C to denature the template and 2.5 units ofTaq polymerase (Cetus Corp., Emeryville, CA) were added. The reaction conditions were 1 min at 94°C, 1 min at 65°C for 15 cycles, followed by 1 min at 94°C, 2 min at 65°C for 15 cycles, followed by 7 min at 72°C. 10% of the PCR reaction was electrophoresed through a 1.0% agarose gel containing ethidium bromide to visualize the product. The amplified product was 1,234 bp in length, containing half of exon 2 and intron 2 and the entire exon 3. A 243-bp fragment (exon 3) was cut using the BamHI site which had been included in the LIF3 oligonucleotide and a SmaI site at position 1171. This fragment was cloned into the BamHI/SmaI sites of pBluescriptKS. The identity of the clone was determined by dideoxy sequencing, using T7 DNA polymerase.
For development of a probe for I8-actin two 15-bp oligonucleotides (5'-CGTCGTCGACAACGG-3' and 5'-GACCGTAGCACTACC-3') defining a 216-bp fragment ofthe cDNA were designed. The restriction sites EcoRI and HindIII were added at their 5' ends, respectively. After amplification by PCR the fragment was inserted into pGEM-4z (Promega Corp., Madison, WI).
The recombinant plasmids were linearized and transcribed with the T7 or T3 RNA polymerase to obtain antisense and sense probes, respectively. For Northern blotting, the probes were labeled with [32P]UTP.
(Amersham Corp.) and separated from unincorporated nucleotides by gel filtration (Centri-sep columns, Princeton Separations, Adelphia, NJ). The probes for in situ hybridization were generated in the presence of [35S]UTP. After transcription, the template was digested with DNase and the products were recovered by phenol extraction and ethanol precipitation. The specific activity was -2 x 10' dpm/,ug template.
Northern blot hybridization. Synoviocytes and chondrocytes were maintained in T175 flasks and stimulated as indicated for each experiment. Total RNA was extracted by the single-step guanidinium thiocyanate-phenol-chloroform method (38). 10-30 Mg oftotal RNA was separated on 1% formaldehyde gels, blotted onto nylon filters, and crosslinked with UV light for 5 min on each side. The blots were prehybridized in 50% formamide, 6xSSC, 0.5% SDS, 0.1 % Tween 20, 100 Mg of yeast RNA/ml for 15 min at 65°C. The prehybridization mixture was replaced with fresh solution containing 106 cpm/ml of probe. Hybridization was performed overnight at 65°C and followed by washes in 1xSSC, 0.1% SDS at room temperature (twice for 30 min) and 0.1xSSC, 0.1% SDS at 65°C (twice for 30 min). The damp filters were exposed to Kodak XAR film at -70°C for 2-24 h. To confirm equal RNA load and complete transfer the 18S and 28S bands were visualized with ethidium bromide on all filters. In addition, RNA load was examined by probing for 13-actin mRNA.
In situ hybridization. Synovial tissues and cartilage organ cultures were snap frozen in dry ice/2-methyl-butane and stored at -70°C until use. Frozen sections (5 Mm) were cut and mounted onto precleaned slides (Fisher Scientific Co., San Francisco, CA). They were fixed in 4% paraformaldehyde, washed in IxPBS, and transferred to 2XSSC. Hybridization was performed as described elsewhere (39) . In brief, the specimens were acetylated in triethanolamine with acetic anhydride and incubated in glycine buffer. Hybridization was carried out with I05 cpm/Mul ofprobe in 50% Formamide, 3xSSC, 500 Mg/ml yeast tRNA, 1 mg/ml single-stranded calf thymus DNA, 2 mg/ml BSA, 10 mM DTT, and 1% polyethylene glycol (PEG) overnight at 50°C. Posthybridization treatment consisted of washes with 2XSSC, 50% formamide at 50°C, incubation with RNase solution, and further washes in 2xSSC at 55°C and thereafter in 2xSSC at room tempera-ture. Specimens were dehydrated, air-dried and covered with Kodak NTB nuclear track emulsion (Eastman Kodak Co.) for autoradiography. After exposure for 8 d at 4°C, the slides were developed, fixed and counterstained with Giemsa. Cells were considered positive, when there were > 20 granules over nucleus and cytoplasm. A replicate slide was hybridized with a sense probe of LIF to serve as negative controls for each condition.
Reagents. The following reagents were used: recombinant human transforming growth factor (TGF-f1) platelet-derived growth factor (PDGF), IL-1, TNFa, LIF, IL-6, granulocyte/macrophage colonystimulating factor (GM-CSF), and rabbit antibody to recombinant human LIF (R&D Systems, Minneapolis, MN); Dexamethasone, PMA, cAMP, Ca ionophore (A23187), and LPS from Salmonella Minnesota (Sigma Chemical Co.).
LIF bioassay. Biological activity of LIF was measured with the factor-dependent human erythroleukemia cell line TF-1. These cells are known to proliferate in response to LIF, GM-CSF, IL-3, and erythropoietin (40) . The cell line which was originally described by Kitamura et al. (40) was kindly provided by R&D Systems (Minneapolis, MN). TF-l cells were maintained in RPMI 1640 supplemented with 10% FBS, penicillin-streptomycin, and recombinant human GM-CSF ( I ng/ml), and split twice per week to I04 cells/ml. For use in the LIF assay the cells were washed three times in RPMI 1640 and 10,000 cells were added per well in 96-well flat-bottom plates in RPMI 5% FBS. The cells were cultured in the presence oftest samples for 48 h when proliferation was measured by the MTT assay ( 15 ) . LIF activity in synovial fluids or conditioned media was determined on the basis of a standard curve using recombinant human LIF and by neutralization ofthe TF-1 cell stimulatory activity in the test samples with a LIF-specific antibody. This antibody does not react with TNF-a, TNF-,B, GM-CSF, G-CSF, PDGF-AA, PDGF-BB, TGF-a, TGF-,B, basic fibroblast growth factor (bFGF), IL-1, IL-2, IL-3, IL-4, IL-6, IL-7, or IL-8.
Results
LIF activity in synovial fluid. Synovial fluids from patients with RA or OA were analyzed for their ability to stimulate proliferation of the factor-dependent cell line TF-1. All samples caused an increase in TF-1 proliferation when tested at a 1:10 dilution which gave optimal stimulation. Synovial fluids from patients with rheumatoid arthritis had higher titers of activity than those from patients with osteoarthritis ( Fig. 1) . To determine the amount of this activity that was due to the presence of LIF, antibody neutralization was performed and this showed that all samples contained LIF (Fig. 1 ) ments the effects ofrecombinant peptide regulatory factors and other agents on the steady state levels of LIF mRNA were analyzed in serum-free media with cells that had been cultured in the absence of serum (serum-starved) for at least 16 h.
We first tested the effects of IL-I and TGF# on LIF mRNA levels. Receptors for IL-1 and TGF-(3 are known to be expressed on chondrocytes and these two factors induce qualitatively distinct responses in chondrocytes. Fig. 3 shows that both IL-1O and TGF3 caused a marked increase in LIF mRNA which was already detectable within 2 h of stimulation. The IL-13 effect was maximal by 5 h, started to decline by 8 h and was no longer detectable by 11 h. In contrast, the TGF-#- mediated increase was prolonged and still apparent by h.
The three isoforms TGF-#,(, TGF-/32, and TGF-j33 had similar effects on LIF mRNA levels. Dose-response studies showed that IL-1,B caused a significant increase in LIF mRNA at 0.1 ng/ml and maximal induction between and 10 ng/ml, which is the optimal concentration of most cytokines and growth factors for the induction of cytokines in chondrocytes and synoviocytes. In addition to TGF-3, we analyzed several other chondrocyte growth factors, including bFGF, PDGF, and IGF-I, and found that they also caused a rapid increase in LIF mRNA (Fig. 4) . However, the growth factors differed with respect to the duration of their effect. LIF mRNA levels in cultures treated with bFGF, PDGF, and IGF-I already started to decline by 5 h while the effects of TGF were still maximal at 8 h.
Among other cytokines that are known to regulate chondrocyte function TNFa induced LIF mRNA while IL-6 showed a modest stimulatory effect. LPS also was Signal transduction pathways and induction of LIF gene expression. Only limited information is available on the signal transduction pathways that are involved with the induction of LIF. Fig. 6 shows that in chondrocytes activation of protein kinase C by phorbol ester provides a strong stimulus for the induction of LIF mRNA. In contrast, increases in the levels of intracellular calcium by the calcium ionophore A23187 and activation ofprotein kinase A by dibutyryl cAMP did not cause a detectable increase in LIF mRNA levels when applied as single stimuli or in combination with PMA.
Dexamethasone is a synthetic glucocorticoid which regulates cytokine expression. It profoundly inhibited LIF gene expression induced by PMA and IL-1,B (Fig. 7) . The protein synthesis inhibitor cycloheximide caused a strong increase in LIF mRNA (Fig. 7 B) . These results suggest that activation ofprotein kinase C is the major stimulus sample of the same cartilage specimen led to expression of readily detectable levels of LIF mRNA. Most of the cells expressed the LIF gene and positive cells were found throughout the different cartilage layers.
Rheumatoid synovial tissues contained LIF-positive cells that were scattered throughout the tissue and probably represent type A and/or type B synoviocytes (Fig. 10, A and B) . After stimulation with IL-1,6 for 4 h, interstitial cells and cells associated with the vascular wall also expressed high levels of LIF mRNA. Hybridization of an adjacent section of the same tissue with a LIF sense probe was negative (Fig. 10, C and D programs in development, in responses to injury, and in the pathogenesis of a wide variety of acute and chronic inflammatory disorders that are associated with impaired connective tissue metabolism. Under physiological conditions such as during normal development and in wound healing qualitatively distinct phases of (a) inflammation and protease-mediated connective tissue resorption, (b) inhibition of the expression and function of proteases, and (c) connective tissue cell proliferation and the formation of organ-specific connective tissue can be distinguished. (32) (33) (34) (35) (36) (37) . IL-6 is considered to be a major hepatocyte stimulating factor (7) that induces the production of several acute phase proteins that are increased in the serum of patients with arthritis and are used as markers ofdisease activity. LIF stimulates the production of a similar set of acute phase proteins (30) . The effects of LIF on bone-marrow-derived cells include the stimulation of marrow blasts (25) and megakaryocytes (26) . Based on its expression by joint tissue cells and its presence in joint fluids LIF thus has the potential to contribute to the hepatic acute-phase response, leukocytosis, and thrombocytosis which are often seen in patients with active arthritis. As shown here, LIF increases its own mRNA levels. In addition, LIF also enhances the expression of other cytokines including IL-6, MCP-1, and IL-8 (in preparation). With this property LIF can indirectly stimulate connective tissue cells. Probably more important to connective tissue metabolism are the direct effects of LIF on chondrocytes and synoviocytes. In addition to the induction of other cytokines, we have recently shown that LIF also stimulates the production of the metalloproteinases stromelysin and collagenase (manuscript in preparation). With the induction of other cytokines and of metalloproteinases and the possible inhibition of extracellular matrix synthesis (37) LIF can be characterized as a catabolic cytokine that is qualitatively similar to IL-1 and TNF in its effects on joint tissue cells.
In conclusion, LIF is produced by synoviocytes and chondrocytes and it is present in synovial fluids. Its effects on connective tissue cells characterize it as a catabolic factor that is qualitatively similar to IL-1 and TNF. This cytokine represents a new member of the group factors that are overexpressed in arthritis, induce connective tissue degradation and may contribute to systemic manifestations of arthritis.
